Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Abbott Laboratories stock outperforms competitors despite losses on the day
This was the stock's third consecutive day of losses.
Piper Sandler initiates Abbott Laboratories with "overweight" rating, $131 PT
Piper Sandler initiated coverage on Abbott Laboratories (NYSE:ABT) with an "overweight" rating and a price target of $131 per share. Piper Sandler emphasizes Abbott’s attractive valuation, strong financial outlook,
Abbott Laboratories' Best Segment Just Got Even Better: Is the Stock a Buy?
Let's not forget about Abbott Laboratories' impressive streak of 52 consecutive annual dividend increases, which also makes it a top stock to buy and hold for dividend investors -- arguably one of the better ones on the market. There are plenty of reasons to invest in the stock.
Abbott Laboratories stock underperforms Wednesday when compared to competitors
The stock's fall snapped a two-day winning streak.
How Does Abbott Laboratories (ABT) Stack Up Against Its Industry Peers?
Abbott Laboratories (ABT) stock saw a decline, ending the day at $114.88 which represents a decrease of $-3.25 or -2.75% from the prior close of $118.13. The stock opened at $117.5 and touched a low of $114.
Calculating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Key Insights The projected fair value for Abbott Laboratories is US$132 based on 2 Stage Free Cash Flow to Equity
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT – Research Report) on September 13 and set a
Law
4d
Who Got the Work: O'Melveny Set to Defend Abbott Labs in Digital Privacy Class Action
O'Melveny & Myers is defending
Abbott
Laboratories
in a pending class action against the company and two other ...
18d
on MSN
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
Abbott Laboratories announced Lingo, its first over-the-counter continuous glucose monitor, is available in the U.S.
3d
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech ...
2d
Piper Sandler Initiates Coverage of Abbott Laboratories (LSE:0Q15) with Overweight Recommendation
Fintel reports that on September 19, 2024, Piper Sandler initiated coverage of Abbott Laboratories ( LSE:0Q15) with a Overweight recommendation. What is the Fund Sentiment?
12d
Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Cardiovascular disease is rising, and Abbott Laboratories is well-positioned in the CVD treatment space. Read why I'm neutral ...
4d
Buy Rating on Abbott Laboratories: Undervalued with Strong Growth Prospects Despite NEC Litigation
Adam Maeder, an analyst from Piper Sandler, has initiated a new Buy rating on Abbott Laboratories (ABT). Adam Maeder has given his Buy rating ...
Zacks.com on MSN
4d
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...
drugdeliverybusiness
4d
Class action suit targets Abbott FreeStyle Libre amid claims of data sharing
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Tren de Aragua
Venezuelan gang
Piper Sandler
FreeStyle Libre
Governor of Texas
Feedback